| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.6B | $10.0B | $11.1B | $16.3B | $12.3B | $8.2B | $7.9B | $8.3B |
| Cost of Revenue | $8.2B | $8.6B | $9.5B | $13.5B | $10.4B | $7.0B | $6.9B | $7.2B |
| Gross Profit | $1.3B | $1.5B | $1.6B | $2.8B | $1.9B | $1.1B | $1.0B | $1.2B |
| R&D Expense | — | — | — | — | — | — | $0.0B | — |
| SG&A Expense | $0.9B | $0.9B | $0.9B | $1.1B | $0.9B | $0.6B | $0.5B | $0.5B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.3B | $0.4B | $1.1B | $0.7B | $0.2B | $0.1B | $0.4B |
| EPS (Basic) | $4.87 | $4.98 | $7.00 | $20.67 | $11.93 | $4.04 | $2.47 | $8.17 |
| EPS (Diluted) | $4.84 | $4.94 | $6.95 | $20.59 | $11.85 | $4.02 | $2.47 | $8.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.1B | $7.0B | $7.3B | $7.4B | $6.7B | $5.8B | $5.7B | $2.8B |
| Current Assets | $2.8B | $2.7B | $2.8B | $3.1B | $2.8B | $2.1B | $2.0B | $1.3B |
| Cash & Equivalents | $0.6B | $0.5B | $0.4B | $0.3B | $0.4B | $0.5B | $0.4B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.6B | $1.6B | $1.7B | $1.8B | $1.8B | $1.5B | $1.4B | $0.8B |
| Stockholders' Equity | $4.3B | $4.1B | $4.0B | $3.6B | $2.9B | $2.3B | $2.1B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $1.0B | $1.0B | $0.5B | $0.5B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.2B | $-1.0B | $-0.4B | $-0.1B | $-1.9B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.6B | $-0.0B | $-0.2B | $-0.4B | $1.5B | $-0.2B |